Azenta, Inc.

Brooks Automation was set up in 1978, and incorporated in 1994.

Brooks acquired the German company Jenoptik-Infab GmbH, subsidiary of M+W Zander, in 1999 to incorporate its mini-environment technology for 300 mm wafer handling.

In 2002, Brooks Automation, Inc. completed the acquisition of Intelligent Automation Systems, Inc. of Cambridge, Massachusetts, a custom automation company with technology and products for the semiconductor, photonics and life sciences industries.

Brooks Automation acquired the Celigo automated Cell Cytometer product line from Cyntellect, Inc in 2011. The same year, Brooks acquired Nexus Biosystems, which produced compound and sample management systems. The following year the company acquired intangible assets from Intevac, Inc. and acquired Crossing Automation Inc.

In October 2012, Brooks Automation entered into an agreement to acquire Crossing Automation Inc.

In April 2014, Brooks Automation entered into an agreement to sell its Granville-Phillips division to MKS Instruments.

Brooks closed the sale of Granville-Phillips to MKS Instruments on May 30, 2014.

Brooks automation announced the acquisition of Biostorage Technologies on 1 December 2015.

In 2017, Brooks acquired 4titude, a maker of scientific tools and consumables, while in 2018, Brooks acquired GENEWIZ, a genomics services provider as part of their life sciences division's expansion.

In November 2021, Brooks Automation Inc. split into two entities, Brooks Automation and Azenta Life Sciences. The latter will focus exclusively on their life science division.

In August 2022, Azenta Life Sciences has come to a definitive agreement to acquire B Medical Systems S.á.r.l., in a transaction of approx. €410 million (with an additional €50 million in future performance milestones) is expected to be completed by October 2022.